Italian neonatologists and SARS-CoV-2: lessons learned to face coming new waves

Abstract

Abstract

The aim of this review was threefold: (a) to retrieve all SARS-CoV-2 evidences published by Italian neonatologists working in maternity centers and NICUs during the pandemic; (b) to summarize current evidence for the management of term and preterm infants with a SARS-CoV-2-related illness; and (c) to provide an update for dealing with the second wave of COVID-19 and discuss open questions. A review was conducted using MEDLINE/PubMed and the national COVID-19 registry of the Italian Society of Neonatology including citations from December 1, 2019 to October 28, 2020. Sixty-three articles were included. Collected data were divided into the following topics: (a) antenatal management, (b) management in delivery room, (c) postnatal management, (d) mother–baby dyad and breastfeeding management, (e) neonatal emergency transport system reorganization, (f) parents’ management and perspective during SARS-CoV-2 pandemic, and (g) future perspective. Evidences have evolved over the pandemic period and the current review can be useful in the management of the mother–neonate dyad during SARS-CoV-2 future waves. Italian neonatologists have played an active role in producing official guidelines and reporting data that have contributed to improve the care of neonates. A joint European action plan is mandatory to face COVID-19 in neonates with more awareness.

Impact

• A joint European action plan is mandatory to face COVID-19 in neonates with more awareness.

• This review summarizes the available evidences from neonatal COVID-19 management in Italy analyzing all the published paper in this specific field of interest.

• The current review can be useful in the management of the mother–neonate dyad during the SARS-CoV-2 future waves.

Introduction

Italy was one of the most exposed countries to pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leading to a coronavirus disease 2019 (COVID-19) in >600,000 cases and 38,000 deaths.¹

A profound reorganization of the clinical management of patients was necessary to address the SARS-CoV-2 health emergency throughout different levels of care. In the absence of evidence-based guidelines, physicians initially had to rely only on case reports/series and expert opinions for the management of these patients. This uncertainty has led to a little consistency in the management of similar patients in similar settings.

COVID-19 seems a mild disease in children, but neonates and infants <1 year appear to be at higher risk of severe respiratory failure than initially thought² and the exact epidemiology and mechanisms are still under investigation.^3,4

For these reasons, the Italian Society of Neonatology (SIN) and the main Italian neonatal intensive care units (NICUs) have issued documents aimed to offering updated recommendation on the management of the maternal–infant dyad, the reorganization of the maternal wards, the NICUs and its services, and to report and summarize the positive cases.^5,6

The objective of the present review was to retrieve all SARS-CoV-2 evidences published by neonatologists working in maternity centers and NICUs in Italy during the pandemic with the aim to summarize current evidence and open questions for the management of term and preterm infants with a SARS-CoV-2-related illness in NICU, maternal ward, and staff reorganization and to provide an update and guide for dealing with the second wave of COVID-19.

Methods

A review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.⁷ We conducted this research using MEDLINE/PubMed as international database including citations from December 1, 2019 to October 28, 2020, with the following search strategy of free-text terms: “coronavirus” OR “sars-cov-2” OR “covid-19” AND “Italy” AND “newborn” OR “preterm infant” OR “premature” AND “NICU”. We also searched the national COVID-19 registry of the SIN available at: https://www.sin-neonatologia.it/covid-19/.

Inclusion criteria

Studies were eligible for full-text review if they included at least one of the co-authors affiliated to an Italian maternal ward or NICU. Retrospective studies, reviews, clinical or expert opinion, case report, or series were included. No language restrictions were applied.

Study selection

Assessments of the titles, abstracts, and full texts were conducted independently by two investigators (M.E.C. and D.T.). Any disagreement regarding study selection was resolved by discussion with a third reviewer (E.B.). The selection process is summarized in Fig. 1.

Fig. 1.

Flow chart of the study selection process.

Data collection

Data were extracted using a standardized data collection form, which summarized information about authors, author’s center, year and month of publication, study design, topic, and international collaboration.

Data synthesis

We divided the collected data into the following topics: (a) antenatal management, (b) management in delivery room, (c) postnatal management, (d) Mother–baby dyad and breastfeeding management, (e) neonatal emergency transport system (NETS) reorganization, (f) parents’ management and perspective during SARS-CoV-2 pandemic, and (g) future perspective.

Statistical analysis

Since the study designs did not allow carrying out a meaningful meta-analysis, we performed a narrative synthesis of the included studies.

Results

Study selection

Overall, the searches yielded 173 non-duplicated articles. Of them, 101 articles were excluded as not relevant. Eleven studies were furtherly excluded after authors’ affiliation screening, and two additional studies were retrieved via hand search. Ultimately, 63 studies were included in the qualitative synthesis^4,5,8–69 (Fig. 1). All articles were in English. Publication date was from March to October 2020. Sixteen out of 63 were expert or clinical opinion, 16 were reviews or systematic reviews, 15 were observational studies, 12 articles were case reports or series, and 14 were international collaborations (Table 1).

Table 1.

Summary of the included studies.

Author	City	Month, year	Article type	Main topic	International collaboration
Di Mascio D.9	Rome	March, 2020	Systematic review and meta-analysis	Hospitalized pregnant women with a confirmed coronavirus-related illness	Yes
De Rose D. U.10	Rome	April, 2020	Review	Newborns and infants with SARS-CoV-2	No
Ferrazzi E.11	Milan	April, 2020	Retrospective studies	Hospitalized pregnant women with a confirmed coronavirus-related illness	Yes
Trevisanuto D.8	Padova	April, 2020	Clinical opinion	Management of infants born to mothers with suspected or confirmed SARS-CoV-2 infection	Yes
Canarutto D.12	Milan	April, 2020	Case report	Newborn with SARS-CoV-2 infection	No
De Rose D. U.13	Rome	April, 2020	Clinical opinion	Breastfeeding management during SARS-CoV-2 pandemic	No
Salvatori G.14	Rome	May, 2020	Case series	Newborns and mothers with SARS-CoV-2	No
Perrone S.15	Parma	May, 2020	Case report	Newborns born to mother with SARS-CoV-2 infection	No
Perrone S.16	Parma	May, 2020	Case series	Newborns born to mother with SARS-CoV-2 infection	Yes
Pietrasanta C.17	Milan	May, 2020	Clinical opinion	Management of mother and infant with suspected or confirmed SARS-CoV-2 Infection	No
Lista G.18	Milan	May, 2020	Clinical opinion	Fatherhood during SARS-CoV-2 pandemic	No
Cavicchiolo M. E.19	Padova	May, 2020	Clinical opinion	Neonatal transport reorganization during SARS-CoV-2 pandemic	No
Manzoni P.20	Biella	May, 2020	Clinical opinion	Newborns with SARS-CoV-2 infection	Yes
Trevisanuto D.21	Padova	June, 2020	Expert opinion	Management of infants born to mothers with suspected or confirmed SARS-CoV-2 infection	Yes
Liguoro I.22	Udine	June, 2020	Systematic review	Newborns and children with SARS-CoV-2	No
Manzoni P.23	Biella	June, 2020	Review	Management of infants born to mothers with suspected or confirmed SARS-CoV-2 infection	No
Buonsenso D.24	Rome	June, 2020	Case series	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Saccone G.25	Naples	June, 2020	Review	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Gente M.26	Rome	June, 2020	Expert opinion	Neonatal transport reorganization during SARS-CoV-2 pandemic	No
Lavizzari A.27	Milan	June, 2020	Review	Comparison of guidelines for managing neonates during SARS-CoV-2 pandemic	Yes
Bellini C.28	Genoa	June, 2020	Clinical opinion	Neonatal transport reorganization during SARS-CoV-2 pandemic	No
Trevisanuto D.29	Padova	June, 2020	Clinical opinion	Management of infants born to mothers with suspected or confirmed SARS-CoV-2 infection in low-resource setting	Yes
Carosso A.30	Turin	June, 2020	Case report	Newborn born to mother with SARS-CoV-2 infection	No
Cavicchiolo M. E.31	Padova	June, 2020	Clinical opinion	NICU reorganization during SARS-CoV-2 pandemic	No
De Rose D. U.32	Rome	June, 2020	Observational study	Preterm newborn and infants hospitalized in NICU during SARS-CoV-2 pandemic	No
Morniroli D.33	Milan	June, 2020	Expert opinion	Immunology of SARS-CoV-2	No
Marino S.34	Catania	June, 2020	Observational study	Pediatric patients with suspected or confirmed SARS-CoV-2 Infection	No
Bellini C.35	Genoa	June, 2020	Observational study	Neonatal transport reorganization during SARS-CoV-2 pandemic	No
Ferrazzi E. M.36	Milan	June, 2020	Clinical opinion	Obstetric and maternity ward reorganization during SARS-CoV-2 pandemic	No
Trippella G.37	Florence	June, 2020	Review	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Manzoni P.38	Biella	June, 2020	Observational study	Pediatric referrals during COVID-19 pandemic	No
Manzoni P.39	Biella	June, 2020	Systematic review	Newborns with SARS-CoV-2 infection	Yes
Davanzo R.40	Trieste	July, 2020	Clinical opinion	Breastfeeding indication during SARS-CoV-2 pandemic	No
Buonsenso D.41	Rome	July, 2020	Case series	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Tassis B.42	Milan	July, 2020	Observational study	Hospitalized pregnant women during SARS-CoV-2 pandemic	No
Sinelli M. T.43	Monza	July, 2020	Case report	Newborn born to mother with SARS-CoV-2 infection	No
Marzollo R.44	Brescia	July, 2020	Case report	Newborn born to mother with SARS-CoV-2 infection	No
Martinelli I.45	Milan	July, 2020	Case report	Pregnant woman with SARS-CoV-2 infection	No
De Bernardo G.46	Naples	July, 2020	Review	SARS-COV-2-positive newborn	No
Pietrasanta C.47	Milan	July, 2020	Review	Newborns with SARS-CoV-2 infection	No
Della Gatta A. N.48	Bologna	July, 2020	Systematic review	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Parazzini F.49	Milan	July, 2020	Review	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Davanzo R.50	Trieste	July, 2020	Position paper	Breastfeeding indication during SARS-CoV-2 pandemic	Yes
Di Mascio D.51	Rome	August, 2020	Systematic review	Hospitalized pregnant women with a confirmed coronavirus-related illness	Yes
Rava L.52	Rome	August, 2020	Registry protocol	Epidemiology, clinical presentation, and outcomes of pediatric and neonatal SARS-CoV-2 infection	Yes
Cavicchiolo M. E.53	Padova	August, 2020	Observational study	Preterm newborn and infants hospitalized in NICU during SARS-CoV-2 pandemic	No
Savasi V. M.54	Milan	August, 2020	Prospective multicenter cohort study	Hospitalized pregnant women with a confirmed coronavirus-related illness	No
Lavizzari A.55	Milan	August, 2020	Expert opinion	Management of infants born to mothers with suspected or confirmed SARS-CoV-2 infection	Yes
Lugli L.56	Modena	August, 2020	Case report	Breastfeeding during SARS-CoV-2 pandemic	No
Manzoni P.57	Biella	August, 2020	Case report	Child with COVID-19	No
Zannin E.58	Milan	August, 2020	Clinical opinion	Bacterial–viral filters	No
Davanzo R.59	Trieste	August, 2020	Clinical opinion	Management of mother and infant with suspected or confirmed SARS-CoV-2 infection	No
Trevisanuto D.4	Padova	August, 2020	Systematic review	Newborns with SARS-CoV-2 infection	No
Bembich S.60	Trieste	September, 2020	Observational study	Parents’ experience during COVID-19 pandemic	No
Di Mascio D.61	Rome	September, 2020	Retrospective cohort study	Hospitalized pregnant women with a confirmed coronavirus-related illness	Yes
Caporali C.62	Pavia	September, 2020	Observational study	Telemedicine for neurodevelopmental follow‐up in preterm infants during COVID‐19 pandemic	No
Genoni G.5	Novara	September, 2020	Systematic review	Breastfeeding during SARS-CoV-2 pandemic	No
Salvatori G.63	Rome	September, 2020	Observational study	Human milk safety during SARS-CoV-2 pandemic	No
Auriti C.64	Rome	September, 2020	Review	Positive maternal–infant dyads	No
Sperotto F.65	Padova	October, 2020	Observational study	Hospitalized neonates and children during COVID-19 pandemic	No
Costa S.66	Rome	October, 2020	Observational study	Human milk safety during SARS-CoV-2 pandemic	No
Lubrano R.67	Latina	October, 2020	Observational study	Management of pediatric care activity during the COVID-19 emergency and future perspectives	No
Bertino E.68	Turin	October, 2020	Observational study	Human milk safety during SARS-CoV-2 pandemic	No

Antenatal management

Regarding the pre-triage to pregnant women, there was a change in practice during the first months of the pandemic. At the beginning, most maternity centers performed the pre-triage to pregnant women based on temperature and a specific questionnaire before entering the delivery room in order to identify as soon as possible suspected cases. These patients underwent nasopharyngeal swabs and were admitted to isolated facilities or transferred as suspected positives to designated maternity hubs.³⁷ As the months went by, the increasing evidence suggested to perform universal screening with nasopharyngeal swabs to all pregnant women; this practice is now recognized in almost all Italian hospitals.^9,11,31,53 A woman’s partner was allowed to attend the labor and delivery if his SARS-CoV-2 status was known but was not allowed to stay on the postpartum ward or it was permitted with time restrictions.³⁷

Studies suggested concentrating COVID-19 cases, procedures, and medical devices in chosen third-level hub referral hospitals with a NICU.¹⁷

In case of delivery of a confirmed or suspected SARS-CoV-2 mother, the woman was assisted during delivery by a dedicated multidisciplinary team (obstetrician, gynecologist, anesthesiologist, neonatologist, neonatal nurse) in an isolation room and subsequently she was transferred to the maternity ward through a dedicated COVID-19 path, by obstetric staff donned with full personal protective equipment (PPE).¹⁷

There was no evidence to suggest the preferred mode of delivery,^8,21 as vertical transmission rarely occurred,^3,47,64 but studies recommended that suspected or positive woman deliveries should happen in a negative-pressure room, with the infant warmer at least at 2 m (6 feet) or in separate room.²¹

Finally, it was recommended to collect maternal specimens for SARS-CoV-2 testing (placenta, amniotic fluid) after delivery aiming to assess possible vertical transmissions.^21,66

Management in the delivery room

In case of neonatal resuscitation, abovementioned studies^8,21,29 suggested that it could be provided in an adjacent room or in the same room at least 2 m away from the mother with a physical barrier such as a curtain. All aerosol-generating procedures should be performed by using full PPE from the healthcare givers providing neonatal care (e.g., respirators, FFP2 or N95 masks, eye protection, gloves, and gowns).^8,20,21,47

Delayed cord clamping could still be performed as a standard of care, while some author suggested avoiding maternal skin contact.²¹

Skin-to-skin contact was a conflicting topic. Some authors suggested a shared decision-making approach with the parents before the delivery regarding the potential risks and benefits of skin-to-skin care and kangaroo mother care, discussing the risks of exposure to both the neonate and healthcare providers,⁵ others did not recommend skin-to-skin contact.^21,47 Davanzo et al.⁵⁹ recommended skin-to-skin contact as far as mothers could carefully follow measures for infection prevention.

Postnatal management

The decision of the location of newborn’s admittance, nursery vs. mother–baby unit vs. NICU was made based on gestational age, newborn’s condition, need for antibiotics, intravenous fluids, respiratory support, post-delivery maternal conditions, and individual hospital policies.³⁹ Most studies suggested a dedicated, specialized team caring for newborns born from COVID-19 mothers to minimize the transmission and spread of the SARS-CoV-2 among healthcare workers.^8,21,53

If the mother was positive for SARS-CoV-2, the infant should have been tested at or beyond 24 hours after birth. Separate swabs of the nasopharynx, oropharynx, and rectum were recommended depending on the availability and turnaround time of testing facilities.^8,21

Screening at NICU admission was assessed by authors from Padova and Rome.^31,32,53 Although the prevalence of COVID-19-positive infants was low, both NICUs opted for a universal screening of newborns admitted to the Unit, their parents, and staff in order to avoid the spread of the virus in a high-risk ward. This policy allowed to identify early positive asymptomatic individuals, which were 2.2% of screened,⁵³ and it has been demonstrated as the best approach to reduce SARS-CoV-2-related costs.⁶⁹ During the surveillance, no newborns tested positive for SARS-CoV-2.^31,53 Positive neonates should be kept in negative-pressure, isolated rooms, and when receiving respiratory support, the use of bacterial–viral filters would be recommended.^8,58

Mother–baby dyad and breastfeeding management

Rooming in and breastfeeding were considered conflicting topics and changed over time.

Some authors initially suggested a different approach according to mother’s COVID-19 status and clinical conditions. If the maternal COVID-19 status was negative or unknown or if a mother previously identified as COVID-19 positive or under investigation for COVID-19 was asymptomatic or paucisymptomatic at delivery, rooming breastfeeding was recommended.^41,50 A recent study from Lombardy region strengthened the safety of rooming in and breastfeeding in positive women who can take care of their babies, demonstrating that only 1.6% of the enrolled newborns developed postnatal SARS-CoV-2 infection.⁷⁰ On the contrary, when a mother with COVID-19 was too sick to care for the newborn, the neonate was suggested to be managed separately and fed with fresh expressed breast milk, with no need to pasteurize it, as human milk was not believed to be a vehicle of COVID-19.¹³

However, previous articles were more cautious about breastfeeding, in particular for feeding preterm infants admitted to the NICU^21,31 suggesting only pasteurized human breast milk (donor or maternal) or formula milk.¹³

More recently, a case report, published by Lugli et al., and another Italian group described the presence of SARS-CoV-2 RNA in human milk samples. In both cases, no SARS-CoV-2 infection was documented in the babies who received the milk.^56,66

Davanzo et al., in a letter, reinforced the concept of the importance of giving mother’s milk to babies even in case of mother–child separation.⁴⁰

The modality of milk donation, sanitization of milk container, and human milk bank reorganization during SARS-CoV-2 pandemic were also discussed suggesting testing all donor mothers for SARS-CoV-2 and sanitize milk containers using disinfectant wipes containing sodium hypochlorite and gloved hands.¹³

As SARS-CoV-2 is effectively inactivated by pasteurization at 62.5 °C for 30 min, universal screening of human milk bank samples and surfaces containers in order to detect SARS-CoV-2 has not been supported.⁶³

Discharge criterion were also discussed: laboratory resolution of the infection (i.e., two negative nasopharyngeal swabs 24 h apart) was not considered a mandatory criterion for discharge. In case of positive mother or infant, provided good clinical conditions of both, the whole family is quarantined home.¹⁷ A strict follow-up of these families has been recommended.²¹

NETS reorganization

NETS is an essential service for centralizing SARS-CoV-2-positive or suspected newborns. During the pandemic period, it needed reorganization in terms of safety for the patients and the clinicians. Neonatal and pediatric working groups of the transport section of the European Society of Paediatric and Neonatal Intensive Care, the Neonatal Transport Study Group of the SIN, and a group of neonatologists of Veneto region published recommendations for this purpose.^19,26,28 Use of individual protective N95 respirator (FFP3 mask), disposable water-repellent with long sleeves gown, double gloves, visor/goggles, disposable headgear, and disposable shoes has been recommended. The guidelines also indicated how to proceed to the disinfection of the transport incubator, the monitors, and ventilator with appropriate solutions, as well as all the equipment (i.e., masks, laryngoscope, self-inflating bag), which should be disposed or sterilized according to standard procedure. Guidelines also recommend storing protective wear equipment inside the ambulance in case of an unscheduled high risk for COVID-19 transport. Bellini et al.³⁵ collected NETS data during the pandemic period and demonstrated that all the newly introduced procedures to perform a safe COVID-19 transport, in particular dressing and undressing procedures, doubled the total transport time.

Parents’ management and perspective during SARS-CoV-2 pandemic

Parents were allowed to visit their babies with some restrictions: they should have been periodically tested for SARS-CoV-2 through nasopharyngeal swabs with a negative result; furthermore, the use of PPE was mandatory.

Two articles analyzed parents’ perspective during COVID-19 pandemic. Lista and Bresesti¹⁸ expressed his opinion as neonatologist who faced the problem of fatherhood during SARS-CoV-2. The author underlined the importance to give more active support to new families by all the healthcare providers involved with birth. Bembich et al. conducted an interview to parents of infants hospitalized in NICU about COVID-19 visitor restriction reporting that most parents expressed dysphoric emotions and relational suffering, indicating that it was very difficult for them to deal with such policies.⁶⁰

Future perspectives

In the pandemic period, telemedicine was implemented to perform non-urgent consultation and for neurodevelopmental follow‐up in preterm infants, with a positive feedback from healthcare providers and parents.^34,36,38

Table 2 summarized the key points for managing the second wave of SARS-CoV-2 pandemic.

Table 2.

Future perspective on the management of the mother–newborn dyad during SARS-CoV-2 second wave.

Antenatal management	Management in the delivery room	Postnatal management		Discharge criterion	Neonatal emergency transport system (NETS) reorganization	Parents’ management and perspective during SARS-CoV-2 pandemic	Pediatric care activity during SARS-CoV-2 pandemic	Knowledge gaps Future directions
Nasopharyngeal swab for all pregnant women at admission Transferred as suspected positives to third-level maternity hubs Partners allowed to attend the labor and delivery if SARS-CoV-2 known status Woman SARS-CoV-2 positive: dedicated multidisciplinary team donned with full personal protective equipment (PPE) during delivery in a negative-pressure isolated room Transfer to the maternity ward through a dedicated COVID-19 route No evidence to suggest preferred mode of delivery Collect maternal specimens for SARS-CoV-2 testing (placenta, amniotic fluid)	Infant warmer at least at 2 m or in another room All aerosol-generating procedures should be performed by using full PPE from the healthcare givers providing neonatal care Delayed cord clamping and maternal skin contact should be performed following strictly hygienic rules (shared decision-making with parents)	(a) Maternity ward	Born from a positive mother: nasopharyngeal and oropharyngeal swabs at birth (within the first 12 h); if negative, second testing before discharge No need for separation of the dyad if mother and child in good clinical conditions; infant cared in an isolette, but kept 2 m from mother except during feeding; mother wears a mask and hand hygiene Breastfeeding with PPE; in case of mother too sick to care for the newborn: express milk by a negative caregiver, pasteurization not recommended	Clinical condition of the dyad If positive mother: discharge with contact and droplet precautions until negative nasopharyngeal swab; quarantine at home Retest of the newborn with nasopharyngeal swabs at 15 and 30 days Close follow-up through video visits (telemedicine)	NETS staff wore N95 respirator (FFP3 mask), disposable water-repellent with long sleeves gown, double gloves, visor/goggles, disposable headgear and disposable shoes Disinfection of the transport incubator, the monitors, and ventilator with appropriate solutions Equipment (i.e., masks, laryngoscope, self-inflating bag) disposed or sterilized according to standard procedure	Parents needed to be tested for SARS-CoV-2 periodically Restriction to one parent per time Time limitation to visitor Psychological support, if available	Implementation of telemedicine for non-urgent consultation Telemedicine also for neurodevelopmental follow‐up in preterm infants	Data on safety for vaccination in pregnant women Passive immunization of the fetus by placental passage of antibodies after maternal vaccination Passive immunization for breastfed infants after maternal vaccination
		(b) NICU	Universal screening for parents, newborns, and healthcare providers Positive newborn: isolated, negative-pressure room, dedicated personnel with PPE Symptomatic and supportive therapy; no antiviral agents approved for newborns (used according to local protocols)					Universal screening Support of mother–infant dyad and breastfeeding Implementation of the use of telemedicine Family-centered perspective

Discussion

The COVID-19 pandemic has put under pressure all the national health systems across Europe, but unfortunately, there has been a poor coordination between countries in the management of these SARS-CoV-2 outbreaks.⁷¹

This review summarizes the available evidence from neonatal COVID-19 management in Italy analyzing all the published paper in this specific field of interest. Most of the retrieved papers were clinical opinion or position paper, which means that the majority of recommendations were not evidence based.

Despite this paucity of information about SARS-CoV-2 at the beginning of the pandemic and the absence of consensus guidelines, our review shows that most of the Italian maternity and neonatal wards adopted similar approaches and they optimize patients’ management overtime. Our results demonstrate a less restrictive testing model in the papers published at the beginning of the pandemic, when most centers tested only symptomatic pregnant women for SARS-CoV-2 with a change to a screening policy of all pregnant women overtime.⁷² On the other hand, the management of newborns of infected or suspected mothers was initially more restrictive in some hospitals: these neonates were placed in isolation rooms based on the available literature at that time and they were fed by formula milk,^8,21 separation of the dyad was recommended for all the hospitalizations based on Chinese guidelines, the only country who experienced COVID-19 before the arrival of the infection in Italy in February 2020.⁷² However, this full restrictive approach was not supported by the official guidelines of the SIN that continued to recommend both skin-to-skin contact and breastfeeding with hygienic measures since beginning of the pandemic according to the World Health Organization and UNICEF recommendations.⁶ In the following months, when positive asymptomatic cases dramatically increased, Italian maternity wards opted for a universal screening approach, testing all pregnant women admitted for delivery, their newborns, and their partners. This approach detected a 2.2% of positive individuals, who were asymptomatic, and likely contributed to avoid a spread of the virus in high-risk wards, such as NICUs.⁵³ Nowadays, universal screening approach could be considered an even more precious approach as new variants, which seem more contagious for children and younger people, are spreading through Europe.⁷³

Separation of the dyad occurred only if the mother was too sick for caring for the baby or when the infants needed intensive care. Mothers were encouraged to provide breastfeeding while rooming-in, following appropriate isolation precautions based on the Centers for Disease Control and Prevention guidance.⁷⁴ Skin-to-skin care was allowed with PPE and hygienic measures. Healthy asymptomatic newborns were generally discharged early and left to a healthy asymptomatic caregiver. Systematic reviews and meta-analysis demonstrated that mother–neonate rooming-in was associated with a higher incidence of SARS-CoV-2 infections,³ but approximately half of the infected neonates were asymptomatic, and if they developed COVID-19, outcome was generally favorable.^3,4,61

Breastfeeding was a conflicted topic. There were few case reports demonstrating SARS-CoV-2 RNA presence in non-pasteurized human milk, but no evidence of infection in newborn fed with positive milk, suggesting a possible protective role of the immunoglobulins included in the human milk.^56,66,68

A recent systematic review of all the published guidelines highlighted that all documents recommend breastfeeding or feeding with expressed maternal milk with the only exception for the Chinese recommendations.⁵ In the setting of COVID-19, studies demonstrated that separation of mother–newborn dyads impacts breastfeeding outcomes, with lower rates of breastfeeding both during hospitalization and at home.^5,75 The SIN promoted breastfeeding during SARS-CoV-2 pandemic, even in positive symptomatic women, following strictly hygienic rules.⁶

Despite the importance, psychological and emotional aspects caused by SARS-CoV-2 restriction in maternity wards and in NICUs were studied only in two papers.^18,60

Telemedicine was considered a useful tool for non-urgent follow-up consultation both from healthcare providers and parents and needed to be implemented.^62,67

Current evidences are missing on the safety and efficacy of vaccination against SARS-CoV-2 of pregnant and lactating women. Even though these categories were not included in the development and clinical evaluation of COVID-19 vaccines in the pre-market phase, the Italian Health Institute⁷⁶ and SIN,⁷⁷ in line with most of the international societies and agencies,^78–80 suggested vaccination for both groups when at high risk of exposure to SARS-CoV-2 or who have comorbidities, which can lead to a more severe disease. Regarding the timing of the vaccination, since no data were available on its safety during pregnancy, the Italian Health Institute suggested delaying it in the second trimester, to avoid situations at increased risk for the fetus in the first trimester (e.g., neural tube defects related to fever or miscarriage).⁷⁶ A recent preprint paper describes the first case of anti-SARS-CoV-2 antibodies detected in the cord blood of a neonate born to a mother immunized with the first dose of an mRNA COVID-19 vaccine 3 weeks earlier. A burning question is to evaluate on larger cohorts the protection of the newborn by placental passage of antibodies as for influenza and pertussis vaccination.⁸¹

Our hope in the next few months lies in the possibility of sharing the acquired knowledge on a larger scale in a European effort in order to fight this pandemic as rapidly and decisively as possible.

Conclusion

There was a paucity of quality of data regarding the management of mother and neonates during SARS-CoV-2 pandemic. Nevertheless, our review shows a change toward universal screening, support of safe mother–infant dyad and breastfeeding, implementation of the use of telemedicine, and a family-centered perspective. Evidence and suggestions evolved over the pandemic period and the current review can be useful in the management of the mother–neonate dyad during the SARS-CoV-2 second wave. National scientific societies, such as the SIN, have played a central role in coordinating and guiding every-day clinical practices in this challenging time. Italian neonatologists have played an active role in producing official guidelines and reporting data that have contributed to improve the care of neonates. A joint European action plan is mandatory to face COVID-19 with more awareness.

Author contributions

M.E.C. wrote the initial draft and revised the literature and approved the final manuscript as submitted. D.T. contributed to write the draft and revised the literature and approved the final manuscript as submitted. E.P. and L.M. critically reviewed the manuscript. F.M. provided relevant expertize and critically reviewed the manuscript. E.B. contributed to the study concept, study design, and writing of the manuscript and critically reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Competing interests

The authors declare no competing interests.

Patient consent

Patient consent was not required.